Case–non-case studies: Principle, methods, bias and interpretation

2019/01/30 by Jean-Luc Faillie, Jean‐Luc Faillie · 7 citations
Pharmacology, Toxicology and Pharmaceutics · Computer Science · Immunology and Microbiology · #Pharmacovigilance and Adverse Drug Reactions #Computational Drug Discovery Methods #Biosimilars and Bioanalytical Methods

paper · doi:10.1016/j.therap.2019.01.006

Citations

• Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System

Cited by

• Uses of pharmacovigilance databases: An overview
• Sex differences in adverse drug reactions: Are women more impacted?
• Drug-induced hyperglycemia and diabetes
• Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis
• PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
• Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis
• The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration